TY - JOUR
T1 - Lack of intersite GABA receptor subtype antagonist effects upon μ opioid receptor agonist-induced feeding elicited from either the ventral tegmental area or nucleus accumbens shell in rats
AU - Ackerman, Tsippa F.
AU - Lamonte, Nicole
AU - Bodnar, Richard J.
N1 - Funding Information:
This research was supported by the National Science Foundation Grant IBN 98-166699 to RJB.
PY - 2003/7
Y1 - 2003/7
N2 - Pretreatment with the GABAA receptor antagonist, bicuculline or the GABAB receptor antagonist, saclofen, into the nucleus accumbens (Nacc) shell, respectively, potentiates and reduces feeding elicited by the μ opioid agonist, [D-Ala2, Nme4, Gly-ol5]-enkephalin (DAMGO), administered into the same site. DAMGO-induced feeding elicited from the ventral tegmental area (VTA) region is significantly reduced by pretreatment with saclofen into the same site indicating local GABA mediation of opioid-induced feeding in each site. Given the neuroanatomical and functional connections between the two sites, the present study evaluated the dose-dependent actions of bicuculline and saclofen pretreatment in one site upon DAMGO-induced feeding elicited from the second site. Pretreatment of either bicuculline (7.5-75 ng) or saclofen (1.5-10 μg) into the Nacc shell failed to alter the time course or magnitude of DAMGO-induced feeding elicited from the VTA region. DAMGO-induced feeding elicited from the Nacc shell was unaffected by VTA region pretreatment with either bicuculline (7.5-75 ng) or saclofen (1.5-5 μg). A higher (10 μg) saclofen dose prevented significant DAMGO-induced feeding after 1 and 4 h. Thus, although GABA receptor subtype antagonists are capable of differentially modulating DAMGO-induced feeding when both drugs are applied locally in either the VTA region or the Nacc shell, it appears that any effects between the VTA region and the Nacc shell in modulating DAMGO-induced feeding do not depend upon a GABAergic synapse in the other site.
AB - Pretreatment with the GABAA receptor antagonist, bicuculline or the GABAB receptor antagonist, saclofen, into the nucleus accumbens (Nacc) shell, respectively, potentiates and reduces feeding elicited by the μ opioid agonist, [D-Ala2, Nme4, Gly-ol5]-enkephalin (DAMGO), administered into the same site. DAMGO-induced feeding elicited from the ventral tegmental area (VTA) region is significantly reduced by pretreatment with saclofen into the same site indicating local GABA mediation of opioid-induced feeding in each site. Given the neuroanatomical and functional connections between the two sites, the present study evaluated the dose-dependent actions of bicuculline and saclofen pretreatment in one site upon DAMGO-induced feeding elicited from the second site. Pretreatment of either bicuculline (7.5-75 ng) or saclofen (1.5-10 μg) into the Nacc shell failed to alter the time course or magnitude of DAMGO-induced feeding elicited from the VTA region. DAMGO-induced feeding elicited from the Nacc shell was unaffected by VTA region pretreatment with either bicuculline (7.5-75 ng) or saclofen (1.5-5 μg). A higher (10 μg) saclofen dose prevented significant DAMGO-induced feeding after 1 and 4 h. Thus, although GABA receptor subtype antagonists are capable of differentially modulating DAMGO-induced feeding when both drugs are applied locally in either the VTA region or the Nacc shell, it appears that any effects between the VTA region and the Nacc shell in modulating DAMGO-induced feeding do not depend upon a GABAergic synapse in the other site.
KW - Bicuculline
KW - Feeding
KW - Nucleus accumbens shell
KW - Saclofen
KW - Ventral tegmental area region
KW - [D-Ala, Nme, Gly-ol]-enkephalin
UR - https://www.scopus.com/pages/publications/0037756751
U2 - 10.1016/S0031-9384(03)00087-8
DO - 10.1016/S0031-9384(03)00087-8
M3 - Article
C2 - 12834790
AN - SCOPUS:0037756751
SN - 0031-9384
VL - 79
SP - 191
EP - 198
JO - Physiology and Behavior
JF - Physiology and Behavior
IS - 2
ER -